SCHOCH CHARLES (Chief Financial Officer) received a stock award from CANDEL THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/26/2025ACC: 0000950170-25-090193
Officer· Chief Financial Officer
Since Jan 2026
+5.35K
Net shares
Net buyer
$25.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
5.35K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.35K
Price / share
$4.67
Trade value
$25K
% of position
14.1%
6/25/2025
38.04K→43.39K
Total
Net shares
+5.35K
Net value
$25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/25/2025 | A · Award | +5.35K | $4.67 | $25K | 14.1% | 38.04K | 43.39K |
| Total | +5.35K | $25K | ||||||
Derivative Transactions0
No derivative transactions reported